Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05537233 · ClinicalTrials.gov registry record · Phase 2

ADJUnct Semaglutide Treatment in Type 1 Diabetes

A Phase 2 study of Obesity and Type 1 Diabetes, sponsored by Viral N. Shah.

Completed
Registry status
Phase 2
Development phase
115
Enrollment target
4
Study locations

NCT05537233: Completed Phase 2 study of Obesity and Type 1 Diabetes, sponsored by Viral N. Shah.

NCT05537233 is a Phase 2 study of Obesity and Type 1 Diabetes that has completed, run by Viral N. Shah. The registered enrollment target is 115 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05537233, a Phase 2 study of Obesity and Type 1 Diabetes, has completed, sponsored by Viral N. Shah.

COMPLETED
Registry status
Phase 2
Development phase
115 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to assess the use of once weekly semaglutide injection in inadequately controlled obese adults with type 1 diabetes (T1D) using FDA-approved hybrid closed-loop therapies.

Conditions Studied

Obesity Type 1 Diabetes

Interventions

  • DRUG Placebo
  • DRUG Semaglutide

Study Locations (4)

Colorado

  • Barbara Davis Center for Diabetes - Aurora

Iowa

  • Iowa Diabetes Research Center - West Des Moines

Michigan

  • Henry Ford Hospital - Detroit

Oregon

  • Harold Schnitzer Diabetes Health Center - Portland

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2023-04-11
Est. Completion 2024-08-06
Phase Phase 2

Sponsor

Viral N. Shah

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05537233

The ClinicalTrials.gov registry entry for NCT05537233 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower). The listed sponsor is Viral N. Shah, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05537233 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Colorado, Iowa, Michigan.

Frequently Asked Questions

What is clinical trial NCT05537233 about?

NCT05537233 is a clinical study titled "ADJUnct Semaglutide Treatment in Type 1 Diabetes". The purpose of this study is to assess the use of once weekly semaglutide injection in inadequately controlled obese adults with type 1 diabetes (T1D) using FDA-approved hybrid closed-loop therapies.

What is the current status of trial NCT05537233?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 115 participants. The study started on 2023-04-11. Estimated completion is 2024-08-06.

What conditions does trial NCT05537233 study?

This clinical trial studies the following conditions: Obesity, Type 1 Diabetes.

What interventions are being tested in trial NCT05537233?

The interventions under investigation include: Placebo (DRUG), Semaglutide (DRUG).

Who is sponsoring clinical trial NCT05537233?

This trial is sponsored by Viral N. Shah, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05537233 being conducted?

This trial has 4 study locations across Colorado, Iowa, Michigan, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Type 1 Diabetes

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.